Suchergebnisse - "Knudsen, Torben"

PubPharm (106)

31

Mathematical modelling of SARS-CoV-2 variant outbreaks reveals their probability of extinction

enthalten in: bioRxiv.org | 2022

von Schiøler, H. | Knudsen, T. | Brøndum, R. | +2

32

Dexmedetomidine and sleep quality in mechanically ventilated critically ill patients : study protocol for a randomised placebo-controlled trial

enthalten in: BMJ open | 2022

von Oxlund, J. | Toft, P. | Sörberg, M. | +2

33

Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases - a Danish nationwide cohort study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Zhao, M. | Sall Jensen, M. | Knudsen, T. | +4

CommentIn: Aliment Pharmacol Ther. 2022 Feb;55(3):370-371. - PMID 35040166

34

Trends in the use of biologicals and their treatment outcomes among patients with inflammatory bowel diseases – a Danish nationwide cohort study

enthalten in: Alimentary Pharmacology & Therapeutics | 2022

von Zhao, M. | Sall Jensen, M. | Knudsen, T. | +4

35

Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway

enthalten in: Alimentary Pharmacology & Therapeutics | 2022

von Zhao, M. | Lirhus, S. | Lördal, M. | +12

36

Diagnostic accuracy of pan‐enteric capsule endoscopy and magnetic resonance enterocolonography in suspected Crohn's disease

enthalten in: United European Gastroenterology Journal | 2022

von Brodersen, J. | Knudsen, T. | Kjeldsen, J. | +3

37

Mathematical modelling of SARS-CoV-2 variant outbreaks reveals their probability of extinction

enthalten in: Scientific reports | 2021

von Schiøler, H. | Knudsen, T. | Brøndum, R. | +2

ErratumIn: Sci Rep. 2022 Aug 30;12(1):14782. - PMID 36042342

38

A New Stochastic Approach for Modeling Glycemic Disturbances in Type 2 Diabetes

enthalten in: IEEE transactions on bio-medical engineering | 2021

von Clausen, H. | Knudsen, T. | Al Ahdab, M. | +4

39

Association between 5-aminosalicylates in patients with IBD and risk of severe COVID-19 : an artefactual result of research methodology?

enthalten in: Gut | 2021

von Attauabi, M. | Seidelin, J. | Burisch, J. | +35

CommentOn: Gut. 2021 Apr;70(4):725-732. - PMID 33082265

40

Vedolizumab as first-line biological therapy in elderly patients and those with contraindications for anti-TNF therapy : a real-world, nationwide cohort of patients with inflammatory bowel diseases

enthalten in: Scandinavian journal of gastroenterology | 2021

von Attauabi, M. | Höglund, C. | Fassov, J. | +19